Endoglin inhibits ERK-induced c-Myc and cyclin D1 expression to impede endothelial cell proliferation

Area of Science:

• Molecular Biology
• Cell Biology
• Biochemistry

Background:

• Endoglin is a crucial TGF-β co-receptor in angiogenesis and vascular remodeling.
• It regulates endothelial cell adhesion, migration, and proliferation via TGF-β signaling pathways.
• The precise mechanisms of endoglin action, particularly its role in cell proliferation, remain incompletely understood.

Purpose of the Study:

• To elucidate the mechanistic role of endoglin and its binding partner β-arrestin2 in regulating endothelial cell proliferation.
• To investigate the signaling pathways involved in endoglin-mediated growth inhibition.

Main Methods:

• Investigated endoglin and β-arrestin2 interactions in endothelial cells.
• Assessed the impact of endoglin on ERK signaling and downstream targets like c-Myc and cyclin D1.
• Examined the effects of disrupting the endoglin/β-arrestin2 complex on cell proliferation and gene expression.

Main Results:

• Endoglin impedes endothelial cell proliferation through sustained inhibition of ERK-induced c-Myc and cyclin D1 expression.
• This inhibitory effect occurs independently of transforming growth factor beta (TGF-β) signaling.
• Disruption of the endoglin/β-arrestin2 interaction reversed growth inhibition and normalized c-Myc and cyclin D1 expression.

Conclusions:

• Endoglin actively inhibits endothelial cell proliferation via a novel TGF-β-independent mechanism targeting ERK signaling.
• The endoglin/β-arrestin2 complex plays a critical role in mediating this growth-suppressive effect.
• These findings reveal a new pathway where endoglin augments growth inhibition by modulating ERK and downstream mitogenic substrates.